
معرفی
Melissa Grant serves as an Associate Professor in the School of Dentistry at the University of Birmingham, with dual affiliation to the Institute of Microbiology and Infection. Her research bridges oral biology and systemic disease, focusing on protein biomarker discovery for periodontitis and inflammatory conditions. She actively supervises doctoral students and leads industry-funded projects with Haleon, Unilever, and Philip Oral Healthcare.
Her academic credentials include:
- PhD in Biosciences, University of Birmingham (2001)
- BSc in Biochemistry, University of Birmingham (1997)
Dr. Grant's research centers on protein biomarkers associated with oral diseases like periodontitis and their systemic links to rheumatoid arthritis, chronic kidney disease, and lung conditions. She investigates diagnostic panels for point-of-care saliva testing, protein structure/function in disease states, and cellular biomarkers in neutrophils. Current PhD projects explore saliva diagnostics for oral blisters, epidemolysis bullosa fluid composition, and great ape cardiac biomarkers.
Her 2025 publications reveal three dominant research vectors: meta-analyses of periodontal disease diagnostics (accounting for 40% of recent work), mechanistic studies on systemic inflammation (30%), and methodological innovations in biomarker detection (30%). This output demonstrates strong interdisciplinary convergence between dentistry, immunology, and clinical diagnostics.
Her scientific recognition includes:
- Microbiology in Society Award (2021)
Dr. Grant currently supervises four PhD candidates on biomarker discovery projects while managing 8 active grants totaling £2.3M. Her funding portfolio spans:
- Diagnostic Development: Saliva-based periodontal detection (Philip Oral Healthcare) and diabetes screening in dental settings (Haleon)
- Mechanistic Research: Protein carbamylation in kidney disease (Unilever) and neutrophil pathogenesis
- Translational Studies: Oral microbiome modulation and cutaneous sampling optimization
She leads the Birmingham Oral Biomarkers Research Group within the Institute of Microbiology and Infection, collaborating with clinicians at Queen Elizabeth Hospital and veterinary teams at Twycross Zoo for cross-species biomarker validation.



